Paul Peter Tak
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $3.2M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 11SEC | CADLCandel Therapeutics, Inc. | Sell Plan | 220,866172,700 held (−56%) | $11.50 | $2.5M | -28.8% |
| Sep 11SEC | CADLCandel Therapeutics, Inc. | Sell Plan | 59,379113,321 held (−34%) | $10.46 | $621K | -21.7% |
- Sell
CEO Paul Peter Tak sold $2.5M of CADL at $11.50 — cuts the stake by 56%; pre-scheduled 10b5-1 plan sale.
- Sell
CEO Paul Peter Tak sold $621K of CADL at $10.46 — cuts the stake by 34%; pre-scheduled 10b5-1 plan sale.